About 40 % of high-risk neuroblastoma contain gene amplification of the transcription factor MYCN often leading to high Mycn expression whereas about 6 % of neuroblastomas contain mutation of ALK, the majority seen in connection to MYCN gene amplification [2]. Here, ALK is linked to neuroblastoma.